Literature DB >> 25705074

Genetics of Vascular Dementia.

Melissa E Murray1, James F Meschia2, Dennis W Dickson1, Owen A Ross1.   

Abstract

Genetic studies are transforming the way we diagnose, evaluate and treat patients. The era of genome-wide association studies promised to discover common risk variants in heterogeneous disorders where previous small-scale association studies had on the whole failed. However, as we enter the post-association era a degree of disappoint is felt regarding the lack of risk factors with large effect for a number of disorders including vascular disease. Vascular disorders are sporadic by nature, though a familial component has been observed. This review will focus on vascular dementia, the genetic risk factors for vascular disorders and highlight how new technologies may overcome the limitations of genome-wide association and nominate those genes that influence disease risk.

Entities:  

Year:  2010        PMID: 25705074      PMCID: PMC4332411     

Source DB:  PubMed          Journal:  Minerva Psichiatr        ISSN: 0374-9320


  141 in total

Review 1.  The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.

Authors:  John Hardy
Journal:  J Neurochem       Date:  2009-05-18       Impact factor: 5.372

Review 2.  Status of risk factors for dementia associated with stroke.

Authors:  P B Gorelick
Journal:  Stroke       Date:  1997-02       Impact factor: 7.914

3.  Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  Sohei Yanagawa; Nobuo Ito; Kunimasa Arima; Shu-ichi Ikeda
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

4.  Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease.

Authors:  B R Winkelmann; A P Russ; M Nauck; B Klein; B O Böhm; V Maier; R Zotz; G Matheis; A Wolf; H Wieland; W Gross; D J Galton; W März
Journal:  Am Heart J       Date:  1999-04       Impact factor: 4.749

5.  Polymorphisms of the phosphodiesterase 4D, cAMP-specific (PDE4D) gene and risk of ischemic stroke: a prospective, nested case-control evaluation.

Authors:  Robert Y L Zee; Victoria H Brophy; Suzanne Cheng; Hillary H Hegener; Henry A Erlich; Paul M Ridker
Journal:  Stroke       Date:  2006-07-06       Impact factor: 7.914

Review 6.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

Review 7.  Cytokine and cytokine receptor polymorphisms in infectious disease.

Authors:  S J van Deventer
Journal:  Intensive Care Med       Date:  2000       Impact factor: 17.440

Review 8.  Recent insights into the molecular genetics of dementia.

Authors:  Rosa Rademakers; Anne Rovelet-Lecrux
Journal:  Trends Neurosci       Date:  2009-07-27       Impact factor: 13.837

9.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

10.  Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease.

Authors:  Kaisa Silander; Hua Tang; Sean Myles; Eveliina Jakkula; Nicholas J Timpson; Luigi Cavalli-Sforza; Leena Peltonen
Journal:  Genome Med       Date:  2009-05-12       Impact factor: 11.117

View more
  1 in total

1.  Genome‑wide DNA methylation profiling in a rat model with vascular dementia.

Authors:  Jong-Min Park; Yoon Ju Kim; Min Kyung Song; Jae-Min Lee; Youn-Jung Kim
Journal:  Mol Med Rep       Date:  2018-05-08       Impact factor: 2.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.